The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Lactate dehydrogenase a in cancer: A promising target for diagnosis and therapy: LDHA in Cancer
Abstract
One of the principal biochemical characteristics of malignant cells compared to normal cells is a metabolic switch from oxidative phosphorylation to increased glycolysis, even under hypoxic conditions, and is termed the Warburg effect. Lactate dehydrogenase A (LDHA) catalyzes the conversion of pyruvate to lactate and is considered to be a key checkpoint of anaerobic glycolysis. It is elevated in many types of cancers and has been linked to tumor growth, maintenance, and invasion; therefore, its inhibition may restrict the energy supply in tumors and thereby reduce the metastatic and invasive potential of cancer cells. This enzyme is receiving a great deal of attention as a potential diagnostic marker or a predictive biomarker for many types of cancer and as a therapeutic target for new anticancer treatments. In this review, we summarize the role of LDHA in cancer, discuss its potential significance in clinical diagnosis and prognosis of cancer, and propose LDHA as a novel target for the inhibition of tumor growth and invasiveness.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian Cancer
Slamon, D. J., Godolphin, W., Jones, L. A., Holt, J. A., Wong, S. G., Keith, D. E., Levin, W. J., Stuart, S. G., Udove, J., Ullrich, A., et al. (1989) · Science · doi:10.1126/science.2470152 · Cited by 6,816
Regulation of cancer cell metabolism
Cairns, R. A., Harris, I. S., & Mak, T. W. (2011) · Nature Reviews Cancer · doi:10.1038/nrc2981 · Cited by 4,744
Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not Anticipate
Ward, P. S., & Thompson, C. B. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.02.014 · Cited by 3,233
Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1.
Semenza, G. L., Roth, P. H., Fang, H. M., & Wang, G. L. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31580-6 · Cited by 1,897
c-Myc Target Genes Involved in Cell Growth, Apoptosis, and Metabolism
Dang, C. V. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.1.1 · Cited by 1,715
Fantin, V. R., St-Pierre, J., & Leder, P. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.04.023 · Cited by 1,635
Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression
Le, A., Cooper, C. R., Gouw, A. M., Dinavahi, R., Maitra, A., Deck, L. M., Royer, R. E., Vander Jagt, D. L., Semenza, G. L., & Dang, C. V. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914433107 · Cited by 1,516
Glycolysis inhibition for anticancer treatment
Pelicano, H., Martin, D. S., Xu, R.-H., & Huang, P. (2006) · Oncogene · doi:10.1038/sj.onc.1209597 · Cited by 1,516
Pyruvate Kinase M2 Is a PHD3-Stimulated Coactivator for Hypoxia-Inducible Factor 1
Luo, W., Hu, H., Chang, R., Zhong, J., Knabel, M., O'Meally, R., Cole, R. N., Pandey, A., & Semenza, G. L. (2011) · Cell · doi:10.1016/j.cell.2011.03.054 · Cited by 1,463
c-Myc transactivation of LDH-A : Implications for tumor metabolism and growth
Shim, H., Dolde, C., Lewis, B. C., Wu, C.-S., Dang, G., Jungmann, R. A., Dalla-Favera, R., & Dang, C. V. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.13.6658 · Cited by 1,092
MYC-Induced Cancer Cell Energy Metabolism and Therapeutic Opportunities
Dang, C. V., Le, A., & Gao, P. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0889 · Cited by 946
ERK1/2-dependent phosphorylation and nuclear translocation of PKM2 promotes the Warburg effect
Yang, W., Zheng, Y., Xia, Y., Ji, H., Chen, X., Guo, F., Lyssiotis, C. A., Aldape, K., Cantley, L. C., & Lu, Z. (2012) · Nature Cell Biology · doi:10.1038/ncb2629 · Cited by 918
AMPK Is a Negative Regulator of the Warburg Effect and Suppresses Tumor Growth In Vivo
Faubert, B., Boily, G., Izreig, S., Griss, T., Samborska, B., Dong, Z., Dupuy, F., Chambers, C., Fuerth, B. J., Viollet, B., et al. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2012.12.001 · Cited by 911
Yao, J. C., Phan, A. T., Chang, D. Z., Wolff, R. A., Hess, K., Gupta, S., Jacobs, C., Mares, J. E., Landgraf, A. N., Rashid, A., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.16.7858 · Cited by 649
Roles of p53, MYC and HIF-1 in regulating glycolysis–the seventh hallmark of cancer
Yeung, S. J., Pan, J., & Lee, M.-H. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8224-x · Cited by 514
Anticancer Targets in the Glycolytic Metabolism of Tumors: A Comprehensive Review
Porporato, P. E., Dhup, S., Dadhich, R. K., Copetti, T., & Sonveaux, P. (2011) · Frontiers in Pharmacology · doi:10.3389/fphar.2011.00049 · Cited by 425
Zhou, M., Zhao, Y., Ding, Y., Liu, H., Liu, Z., Fodstad, O., Riker, A. I., Kamarajugadda, S., Lu, J., Owen, L. B., et al. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-33 · Cited by 395
Zhao, Y. H., Zhou, M., Liu, H., Ding, Y., Khong, H. T., Yu, D., Fodstad, O., & Tan, M. (2009) · Oncogene · doi:10.1038/onc.2009.229 · Cited by 269
Sheng, S. L., Liu, J. J., Dai, Y. H., Sun, X. G., Xiong, X. P., & Huang, G. (2012) · The FEBS Journal · doi:10.1111/j.1742-4658.2012.08748.x · Cited by 263
Self-citationXie, H., Valera, V. A., Merino, M. J., Amato, A. M., Signoretti, S., Linehan, W. M., Sukhatme, V. P., & Seth, P. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-1049 · Cited by 233
Granchi, C., Roy, S., Giacomelli, C., Macchia, M., Tuccinardi, T., Martinelli, A., Lanza, M., Betti, L., Giannaccini, G., Lucacchini, A., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm101007q · Cited by 227
Inhibitors of Lactate Dehydrogenase Isoforms and their Therapeutic Potentials
Granchi, C., Bertini, S., Macchia, M., & Minutolo, F. (2010) · Current Medicinal Chemistry · doi:10.2174/092986710790416263 · Cited by 224
Koukourakis, M. I., Giatromanolaki, A., Sivridis, E., Gatter, K. C., & Harris, A. L. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.05.9501 · Cited by 221
Hecht, J. R., Trarbach, T., Jaeger, E., Hainsworth, J., Wolff, R., Lloyd, K., Bodoky, G., Borner, M., Laurent, D., & Jacques, C. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.23.16_suppl.lba3 · Cited by 201
Sugar-free approaches to cancer cell killing
El Mjiyad, N., Caro-Maldonado, A., Ramírez-Peinado, S., & Muñoz-Pinedo, C. (2011) · Oncogene · doi:10.1038/onc.2010.466 · Cited by 198
Kolev, Y., Uetake, H., Takagi, Y., & Sugihara, K. (2008) · Annals of Surgical Oncology · doi:10.1245/s10434-008-9955-5 · Cited by 191
Luo, W., & Semenza, G. L. (2011) · Oncotarget · doi:10.18632/oncotarget.299 · Cited by 190
Rong, Y., Wu, W., Ni, X., Kuang, T., Jin, D., Wang, D., & Lou, W. (2013) · Tumor Biology · doi:10.1007/s13277-013-0679-1 · Cited by 190
Armstrong, A. J., George, D. J., & Halabi, S. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.40.9631 · Cited by 156
Hypoxia‐inducible factor 1 and cancer pathogenesis
Semenza, G. L. (2008) · IUBMB Life · doi:10.1002/iub.93 · Cited by 153
Alvarez‐Lorenzo, C., Sosnik, A., & Concheiro, Á. (2011) · Current Drug Targets · doi:10.2174/138945011795906615 · Cited by 151
The Interplay Between MYC and HIF in the Warburg Effect
Dang, C. V. (2008) · Ernst Schering Research Foundation workshop/Ernst Schering Foundation Symposium proceedings · doi:10.1007/2789_2008_088 · Cited by 139
LDHA is necessary for the tumorigenicity of esophageal squamous cell carcinoma
Yao, F., Zhao, T., Zhong, C., Zhu, J. J., & Zhao, H. (2012) · Tumor Biology · doi:10.1007/s13277-012-0506-0 · Cited by 135
Koukourakis, M. I., Giatromanolaki, A. N., Sivridis, E., Gatter, K. C., Trarbach, T., Folprecht, G., Shi, M. M., Lebwohl, D., Jalava, T., Laurent, D., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2918 · Cited by 133
Alterations of metabolic genes and metabolites in cancer
Oermann, E. K., Wu, J., Guan, K., & Xiong, Y. (2012) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2012.01.013 · Cited by 126
Brown, J. E., Cook, R. J., Lipton, A., & Coleman, R. E. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-1397 · Cited by 87
Metabolic regulation by lactate
Sola‐Penna, M. (2008) · IUBMB Life · doi:10.1002/iub.97 · Cited by 86
Emerging Metabolic Targets in Cancer Therapy
Zhao, Y., Liu, H., Riker, A. I., Fodstad, Ø., LeDoux, S. P., Wilson, G. L., & Tan, M. (2010) · Frontiers in bioscience · doi:10.2741/3826 · Cited by 85
Ashrafian, H., O′Flaherty, L., Adam, J., Steeples, V., Chung, Y., East, P., Vanharanta, S., Lehtonen, H. J., Nye, E. L., Hatipoglu, E., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1949 · Cited by 72
Azuma, M., Shi, M. M., Danenberg, K. D., Gardner, H., Barrett, C. J., Jacques, C. J., Sherod, A., Iqbal, S., El-Khoueiry, A. B., Yang, D., et al. (2007) · Pharmacogenomics · doi:10.2217/14622416.8.12.1705 · Cited by 69
Zhang, Y., Zhang, X., Wang, X., Gan, L., Yu, G., Chen, Y., Liu, K., Li, P., Pan, J., Wang, J., et al. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.03.013 · Cited by 64
Hypoxia-Induced Lactate Dehydrogenase Expression and Tumor Angiogenesis
Colgan, S. M., Mukherjee, S. D., & Major, P. P. (2007) · Clinical Colorectal Cancer · doi:10.3816/ccc.2007.n.014 · Cited by 41
A systematic review of lactate dehydrogenase isoenzyme 1 and germ cell tumors
von Eyben, F. E. (2001) · Clinical Biochemistry · doi:10.1016/s0009-9120(01)00236-3 · Cited by 38
Langhammer, S., Najjar, M., Hess‐Stumpp, H., & Thierauch, K. (2011) · Targeted Oncology · doi:10.1007/s11523-011-0184-7 · Cited by 36
M-LDH Serves as a Regulatory Subunit of the Cytosolic Substrate-channelling Complex in Vivo
Jovanović, S., Jovanović, A., & Crawford, R. M. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2007.05.081 · Cited by 22
Cited by
Lactate metabolism in human health and disease
Li, X., Yang, Y., Zhang, B., Lin, X., Fu, X., An, Y., Zou, Y., Wang, J.-X., Wang, Z., & Yu, T. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01151-3 · Cited by 1,454
Lactate dehydrogenase A: A key player in carcinogenesis and potential target in cancer therapy
Feng, Y., Xiong, Y., Qiao, T., Li, X., Jia, L., & Han, Y. (2018) · Cancer Medicine · doi:10.1002/cam4.1820 · Cited by 705
Abdel-Wahab, A. F., Mahmoud, W., & Al-Harizy, R. M. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104511 · Cited by 591
The Regulation and Function of Lactate Dehydrogenase A: Therapeutic Potential in Brain Tumor
Valvona, C. J., Fillmore, H. L., Nunn, P. B., & Pilkington, G. J. (2016) · Brain Pathology · doi:10.1111/bpa.12299 · Cited by 567
Brown, T. P., & Ganapathy, V. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.107451 · Cited by 481
Metadata
- Authors
- Miao, P., Sheng, S., Sun, X., Liu, J., & Huang, G.
- Venue
- IUBMB Life
- Publisher
- Wiley
- Published
- 2013-11
- Volume
- 65
- Issue
- 11
- Pages
- 904-910
- ISSN
- 1521-6543 (ISSN-L)
- OpenAlex
- W1574675143
- Cited by
- 422
- References
- 45
- FWCI
- 4.97
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.